Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for targeted cancer therapies. Its structural configuration enables selective binding to specific enzyme active sites, enhancing drug efficacy and reducing off-target effects. Commonly employed in the preparation of biologically active molecules where stereochemistry plays a critical role in activity. Also utilized in asymmetric synthesis and medicinal chemistry research for optimizing lead compounds.